BioCentury
ARTICLE | Clinical News

Abaloparatide-SC regulatory update

April 11, 2016 7:00 AM UTC

Radius submitted an NDA to FDA for abaloparatide-SC to treat osteoporosis in postmenopausal women. An MAA for the subcutaneous peptide analog of parathyroid hormone-related protein (PTHrP) is under EM...